Clinical Trial Update: A Study to Evaluate Adverse Events and Change in Disease Activity With the XEN45 Glaucoma Treatment System Implantation In Adult Participants With Open-Angle Glaucoma in China [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial in China evaluating adverse events and changes in disease activity after implantation of the XEN45 Glaucoma Treatment System in adults …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Open-angle Glaucoma

Drugs mentioned

• XEN45 Glaucoma Treatment System

Snippet

Sponsor: AbbVie | Conditions: Open-angle Glaucoma, OAG | Phase 4 | Status: RECRUITING